According to Biolife Solutions 's latest financial reports the company's total debt is $42.69 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $42.69 M | -2.34% |
2022-12-31 | $43.71 M | 62.63% |
2021-12-31 | $26.87 M | 141% |
2020-12-31 | $11.15 M | 715.87% |
2019-12-31 | $1.36 M | |
2018-12-31 | $N/A | |
2016-12-31 | $2.84 M | |
2013-12-31 | $10.6 M | 0% |
2012-12-31 | $10.6 M | 4.69% |
2011-12-31 | $10.12 M | 12.12% |
2010-12-31 | $9.03 M | 14.52% |
2009-12-31 | $7.88 M | 55.8% |
2008-12-31 | $5.06 M | 84.11% |
2007-12-31 | $2.75 M | 1292.57% |
2006-12-31 | $0.19 M | -12.59% |
2005-12-31 | $0.22 M | |
2003-12-31 | $0.7 M | 104.01% |
2002-12-31 | $0.34 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Celanese CE | $14.09 B | 32,923.35% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $25.49 M | -40.29% | ๐บ๐ธ USA |
Amyris AMRS | $1.03 B | 2,323.16% | ๐บ๐ธ USA |